Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

BACKGROUND: Platinum-based doublet chemotherapy is the standard first-line treatment for advanced non-small cell lung cancer (NSCLC), but earlier studies have suggested that non-platinum combinations are equally effective and better tolerated. We conducted a national, randomised study to compare a n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fløtten, Ø, Grønberg, B H, Bremnes, R, Amundsen, T, Sundstrøm, S, Rolke, H, Hornslien, K, Wentzel-Larsen, T, Aasebø, U, von Plessen, C
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2012
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3405221/
https://ncbi.nlm.nih.gov/pubmed/22759880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars